Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Appay

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Clinical and Experimental Immunology|September 18, 2004
The physiological role of cytotoxic CD4(+) T-cells: the holy grail?V Appay
The Journal of Pathology|December 29, 2007
Immune activation and inflammation in HIV-1 infection: causes and consequencesV Appay, D Sauce
Trends in Immunology|April 5, 2001
RANTES: a versatile and controversial chemokineV Appay, S L Rowland-Jones
The Journal of Biological Chemistry|September 17, 1999
Aggregation of RANTES is responsible for its inflammatory properties. Characterization of nonaggregating, noninflammatory RANTES mutantsV Appay, A Brown, S Cribbes, et al.
International Immunology|August 5, 2000
RANTES activates antigen-specific cytotoxic T lymphocytes in a mitogen-like manner through cell surface aggregationV Appay, P R Dunbar, V Cerundolo, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|February 24, 2001
The dynamics of the cellular immune response to HIV infection: implications for vaccinationA J McMichael, M Callan, V Appay, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|May 4, 2000
Memory CD8+ T cells in HIV infectionA J McMichael, G Ogg, J Wilson, et al.
Clinical and Experimental Immunology|October 20, 2005
Optimum in vitro expansion of human antigen-specific CD8 T cells for adoptive transfer therapyM Montes, N Rufer, V Appay, et al.
Journal of Virology|August 10, 2000
Functional heterogeneity and high frequencies of cytomegalovirus-specific CD8(+) T lymphocytes in healthy seropositive donorsG M Gillespie, M R Wills, V Appay, et al.
Immunology Letters|October 12, 2001
How important is the 'quality' of the cytotoxic T lymphocyte (CTL) response in protection against HIV infection?S L Rowland-Jones, S Pinheiro, R Kaul, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Clinical and Experimental Immunology|September 18, 2004
The physiological role of cytotoxic CD4(+) T-cells: the holy grail?V Appay
The Journal of Pathology|December 29, 2007
Immune activation and inflammation in HIV-1 infection: causes and consequencesV Appay, D Sauce
Trends in Immunology|April 5, 2001
RANTES: a versatile and controversial chemokineV Appay, S L Rowland-Jones
The Journal of Biological Chemistry|September 17, 1999
Aggregation of RANTES is responsible for its inflammatory properties. Characterization of nonaggregating, noninflammatory RANTES mutantsV Appay, A Brown, S Cribbes, et al.
International Immunology|August 5, 2000
RANTES activates antigen-specific cytotoxic T lymphocytes in a mitogen-like manner through cell surface aggregationV Appay, P R Dunbar, V Cerundolo, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|February 24, 2001
The dynamics of the cellular immune response to HIV infection: implications for vaccinationA J McMichael, M Callan, V Appay, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|May 4, 2000
Memory CD8+ T cells in HIV infectionA J McMichael, G Ogg, J Wilson, et al.
Clinical and Experimental Immunology|October 20, 2005
Optimum in vitro expansion of human antigen-specific CD8 T cells for adoptive transfer therapyM Montes, N Rufer, V Appay, et al.
Journal of Virology|August 10, 2000
Functional heterogeneity and high frequencies of cytomegalovirus-specific CD8(+) T lymphocytes in healthy seropositive donorsG M Gillespie, M R Wills, V Appay, et al.
Immunology Letters|October 12, 2001
How important is the 'quality' of the cytotoxic T lymphocyte (CTL) response in protection against HIV infection?S L Rowland-Jones, S Pinheiro, R Kaul, et al.
Pageof 2